fanta.bio Sample: CNhs11740
16798 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1065 / 12902 (8.3%) | 355 / 129020 (0.3%) | −324.0 | −324.0 | 30.00 |
| HIF1A SRX11007095 | HK-2 Kidney | 1962 / 12902 (15.2%) | 747 / 129020 (0.6%) | −324.0 | −324.0 | 26.27 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1480 / 12902 (11.5%) | 623 / 129020 (0.5%) | −324.0 | −324.0 | 23.76 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1352 / 12902 (10.5%) | 647 / 129020 (0.5%) | −324.0 | −324.0 | 20.90 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1815 / 12902 (14.1%) | 965 / 129020 (0.7%) | −324.0 | −324.0 | 18.81 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1846 / 12902 (14.3%) | 1002 / 129020 (0.8%) | −324.0 | −324.0 | 18.42 |
| SCML2 SRX644728 | 293 Kidney | 1051 / 12902 (8.1%) | 670 / 129020 (0.5%) | −324.0 | −324.0 | 15.69 |
| FOXP1 SRX736067 | LNCAP Prostate | 1501 / 12902 (11.6%) | 996 / 129020 (0.8%) | −324.0 | −324.0 | 15.07 |
| MYH11 SRX265221 | ME-1 Blood | 729 / 12902 (5.7%) | 511 / 129020 (0.4%) | −324.0 | −324.0 | 14.27 |
| BRD4 SRX9419935 | BT-474 Breast | 2801 / 12902 (21.7%) | 2393 / 129020 (1.9%) | −324.0 | −324.0 | 11.71 |
| MED1 SRX9419945 | BT-474 Breast | 2777 / 12902 (21.5%) | 2375 / 129020 (1.8%) | −324.0 | −324.0 | 11.69 |
| MED1 SRX9419944 | BT-474 Breast | 2740 / 12902 (21.2%) | 2347 / 129020 (1.8%) | −324.0 | −324.0 | 11.67 |
| BRD4 SRX9419937 | BT-474 Breast | 2801 / 12902 (21.7%) | 2406 / 129020 (1.9%) | −324.0 | −324.0 | 11.64 |
| MED1 SRX9419946 | BT-474 Breast | 2850 / 12902 (22.1%) | 2491 / 129020 (1.9%) | −324.0 | −324.0 | 11.44 |
| BRD4 SRX9419936 | BT-474 Breast | 2846 / 12902 (22.1%) | 2510 / 129020 (1.9%) | −324.0 | −324.0 | 11.34 |
| BRD4 SRX9419938 | BT-474 Breast | 2795 / 12902 (21.7%) | 2502 / 129020 (1.9%) | −324.0 | −324.0 | 11.17 |
| MED1 SRX9419947 | BT-474 Breast | 2740 / 12902 (21.2%) | 2474 / 129020 (1.9%) | −324.0 | −324.0 | 11.08 |
| EZH2 SRX2146136 | LNCAP Prostate | 5922 / 12902 (45.9%) | 6641 / 129020 (5.1%) | −324.0 | −324.0 | 8.92 |
| BRD4 SRX736201 | 90-8TL Neural | 4562 / 12902 (35.4%) | 5324 / 129020 (4.1%) | −324.0 | −324.0 | 8.57 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1441 / 12902 (11.2%) | 2112 / 129020 (1.6%) | −324.0 | −324.0 | 6.82 |
| TP53 SRX19538279 | Osteoblasts Bone | 456 / 12902 (3.5%) | 234 / 129020 (0.2%) | −297.0 | −293.8 | 19.49 |
| HIF1A SRX20663235 | HK-2 Kidney | 442 / 12902 (3.4%) | 218 / 129020 (0.2%) | −291.7 | −288.5 | 20.28 |
| TP53 SRX19538274 | U2OS Bone | 385 / 12902 (3.0%) | 157 / 129020 (0.1%) | −269.3 | −266.1 | 24.52 |
| TP53 SRX19538268 | U2OS Bone | 377 / 12902 (2.9%) | 156 / 129020 (0.1%) | −262.5 | −259.4 | 24.17 |
| TP53 SRX19538276 | U2OS Bone | 375 / 12902 (2.9%) | 161 / 129020 (0.1%) | −258.3 | −255.2 | 23.29 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1092 / 12902 (8.5%) | 2897 / 129020 (2.2%) | −252.3 | −249.2 | 3.77 |
| PBX4 SRX2731658 | PC-3 Prostate | 752 / 12902 (5.8%) | 20302 / 129020 (15.7%) | −244.4 | −241.3 | 0.37 |
| TP53 SRX19538280 | Osteoblasts Bone | 367 / 12902 (2.8%) | 180 / 129020 (0.1%) | −242.4 | −239.4 | 20.39 |
| TP53 SRX19538267 | U2OS Bone | 339 / 12902 (2.6%) | 144 / 129020 (0.1%) | −234.2 | −231.1 | 23.54 |
| TP53 SRX19538275 | U2OS Bone | 343 / 12902 (2.7%) | 162 / 129020 (0.1%) | −229.3 | −226.3 | 21.17 |
| TP53 SRX19538273 | U2OS Bone | 329 / 12902 (2.5%) | 142 / 129020 (0.1%) | −226.2 | −223.2 | 23.17 |
| TP53 SRX19538281 | Osteoblasts Bone | 375 / 12902 (2.9%) | 257 / 129020 (0.2%) | −219.1 | −216.1 | 14.59 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 338 / 12902 (2.6%) | 180 / 129020 (0.1%) | −217.1 | −214.1 | 18.78 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1228 / 12902 (9.5%) | 4055 / 129020 (3.1%) | −215.1 | −212.1 | 3.03 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 533 / 12902 (4.1%) | 745 / 129020 (0.6%) | −213.7 | −210.7 | 7.15 |
| TP53 SRX19538269 | U2OS Bone | 405 / 12902 (3.1%) | 359 / 129020 (0.3%) | −210.8 | −207.9 | 11.28 |
| IRF3 SRX11453858 | Hep G2 Liver | 272 / 12902 (2.1%) | 77 / 129020 (0.1%) | −208.8 | −205.9 | 35.32 |
| AGO2 SRX4708039 | Hep G2 Liver | 1485 / 12902 (11.5%) | 5744 / 129020 (4.5%) | −205.2 | −202.2 | 2.59 |
| TP53 SRX19538270 | U2OS Bone | 386 / 12902 (3.0%) | 342 / 129020 (0.3%) | −201.0 | −198.0 | 11.29 |
| YAP1 SRX757325 | H2052 Lung | 547 / 12902 (4.2%) | 15633 / 129020 (12.1%) | −197.4 | −194.5 | 0.35 |
| FOS SRX150477 | MCF 10A Breast | 524 / 12902 (4.1%) | 15045 / 129020 (11.7%) | −190.4 | −187.5 | 0.35 |
| FOS SRX150478 | MCF 10A Breast | 550 / 12902 (4.3%) | 15365 / 129020 (11.9%) | −188.0 | −185.1 | 0.36 |
| IRF3 SRX11453861 | Hep G2 Liver | 247 / 12902 (1.9%) | 73 / 129020 (0.1%) | −187.8 | −184.9 | 33.84 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 490 / 12902 (3.8%) | 751 / 129020 (0.6%) | −184.0 | −181.2 | 6.52 |
| ESR1 SRX4367193 | MCF-7 Breast | 758 / 12902 (5.9%) | 18287 / 129020 (14.2%) | −183.6 | −180.7 | 0.41 |
| FOXA1 SRX4815198 | MCF-7 Breast | 787 / 12902 (6.1%) | 18592 / 129020 (14.4%) | −180.6 | −177.8 | 0.42 |
| YAP1 SRX757326 | H2052 Lung | 484 / 12902 (3.8%) | 13949 / 129020 (10.8%) | −176.3 | −173.4 | 0.35 |
| FOXA1 SRX176862 | MCF-7 Breast | 292 / 12902 (2.3%) | 10733 / 129020 (8.3%) | −173.9 | −171.0 | 0.27 |
| TP53 SRX19538282 | Osteoblasts Bone | 319 / 12902 (2.5%) | 259 / 129020 (0.2%) | −173.0 | −170.2 | 12.32 |
| BRD4 SRX736204 | 90-8TL Neural | 785 / 12902 (6.1%) | 2172 / 129020 (1.7%) | −171.0 | −168.1 | 3.61 |
| FOXA1 SRX4815197 | MCF-7 Breast | 584 / 12902 (4.5%) | 15175 / 129020 (11.8%) | −167.7 | −164.9 | 0.38 |
| ESR1 SRX7624157 | MCF-7 Breast | 629 / 12902 (4.9%) | 15831 / 129020 (12.3%) | −167.4 | −164.6 | 0.40 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 532 / 12902 (4.1%) | 14380 / 129020 (11.1%) | −167.3 | −164.5 | 0.37 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 474 / 12902 (3.7%) | 797 / 129020 (0.6%) | −166.0 | −163.2 | 5.95 |
| TP53 SRX19538271 | U2OS Bone | 519 / 12902 (4.0%) | 1007 / 129020 (0.8%) | −161.6 | −158.8 | 5.15 |
| BRD1 SRX286203 | RKO Digestive tract | 956 / 12902 (7.4%) | 3233 / 129020 (2.5%) | −160.3 | −157.5 | 2.96 |
| FOXA1 SRX176863 | MCF-7 Breast | 284 / 12902 (2.2%) | 10163 / 129020 (7.9%) | −160.1 | −157.4 | 0.28 |
| ESR1 SRX371478 | MCF-7 Breast | 310 / 12902 (2.4%) | 10540 / 129020 (8.2%) | −158.0 | −155.2 | 0.29 |
| ESR1 SRX20282961 | MCF-7 Breast | 305 / 12902 (2.4%) | 10444 / 129020 (8.1%) | −157.7 | −154.9 | 0.29 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 417 / 12902 (3.2%) | 12234 / 129020 (9.5%) | −156.5 | −153.7 | 0.34 |
| BRPF3 SRX796084 | RKO Digestive tract | 1196 / 12902 (9.3%) | 4738 / 129020 (3.7%) | −156.4 | −153.7 | 2.52 |
| FOS SRX4192880 | MCF 10A Breast | 413 / 12902 (3.2%) | 12163 / 129020 (9.4%) | −156.4 | −153.6 | 0.34 |
| KAT7 SRX101303 | RKO Digestive tract | 1076 / 12902 (8.3%) | 4003 / 129020 (3.1%) | −156.1 | −153.3 | 2.69 |
| ESR1 SRX7624156 | MCF-7 Breast | 397 / 12902 (3.1%) | 11891 / 129020 (9.2%) | −155.8 | −153.1 | 0.33 |
| ESR1 SRX371469 | MCF-7 Breast | 251 / 12902 (1.9%) | 9422 / 129020 (7.3%) | −154.6 | −151.9 | 0.27 |
| ESR1 SRX176860 | MCF-7 Breast | 413 / 12902 (3.2%) | 12101 / 129020 (9.4%) | −154.5 | −151.8 | 0.34 |
| AR SRX1067071 | LHSAR Prostate | 485 / 12902 (3.8%) | 13203 / 129020 (10.2%) | −154.0 | −151.3 | 0.37 |
| ESR1 SRX176861 | MCF-7 Breast | 411 / 12902 (3.2%) | 12047 / 129020 (9.3%) | −153.8 | −151.1 | 0.34 |
| FOXA1 SRX1161177 | MCF-7 Breast | 244 / 12902 (1.9%) | 9263 / 129020 (7.2%) | −153.5 | −150.8 | 0.26 |
| ESR1 SRX20282960 | MCF-7 Breast | 278 / 12902 (2.2%) | 9852 / 129020 (7.6%) | −153.4 | −150.7 | 0.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 287 / 12902 (2.2%) | 9982 / 129020 (7.7%) | −152.6 | −149.9 | 0.29 |
| KAT6A SRX20971022 | Fibroblasts Others | 211 / 12902 (1.6%) | 77 / 129020 (0.1%) | −152.2 | −149.5 | 27.40 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 286 / 12902 (2.2%) | 9938 / 129020 (7.7%) | −151.8 | −149.1 | 0.29 |
| FOXA1 SRX371482 | MCF-7 Breast | 363 / 12902 (2.8%) | 11165 / 129020 (8.7%) | −150.4 | −147.7 | 0.33 |
| GATA3 SRX190239 | MCF-7 Breast | 372 / 12902 (2.9%) | 11306 / 129020 (8.8%) | −150.3 | −147.7 | 0.33 |
| FOXA1 SRX3931044 | MCF-7 Breast | 553 / 12902 (4.3%) | 14090 / 129020 (10.9%) | −150.2 | −147.6 | 0.39 |
| ESR1 SRX371479 | MCF-7 Breast | 227 / 12902 (1.8%) | 8829 / 129020 (6.8%) | −149.2 | −146.6 | 0.26 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 361 / 12902 (2.8%) | 11062 / 129020 (8.6%) | −148.3 | −145.7 | 0.33 |
| AR SRX10820653 | LNCAP Prostate | 257 / 12902 (2.0%) | 183 / 129020 (0.1%) | −147.7 | −145.1 | 14.04 |
| TLE3 SRX4815191 | MCF-7 Breast | 236 / 12902 (1.8%) | 8944 / 129020 (6.9%) | −147.7 | −145.1 | 0.26 |
| FOXA1 SRX371481 | MCF-7 Breast | 268 / 12902 (2.1%) | 9498 / 129020 (7.4%) | −147.7 | −145.1 | 0.28 |
| BRPF3 SRX796085 | RKO Digestive tract | 848 / 12902 (6.6%) | 2809 / 129020 (2.2%) | −145.9 | −143.3 | 3.02 |
| FOXA1 SRX371483 | MCF-7 Breast | 289 / 12902 (2.2%) | 9798 / 129020 (7.6%) | −145.8 | −143.2 | 0.29 |
| FOXA1 SRX1161176 | MCF-7 Breast | 239 / 12902 (1.9%) | 8921 / 129020 (6.9%) | −145.3 | −142.8 | 0.27 |
| ESR1 SRX371471 | ZR-75-1 Breast | 281 / 12902 (2.2%) | 9605 / 129020 (7.4%) | −144.0 | −141.5 | 0.29 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 185 / 12902 (1.4%) | 7904 / 129020 (6.1%) | −143.9 | −141.3 | 0.23 |
| ESR1 SRX4367192 | MCF-7 Breast | 539 / 12902 (4.2%) | 13656 / 129020 (10.6%) | −143.9 | −141.3 | 0.39 |
| ESR1 SRX1531791 | MCF-7 Breast | 246 / 12902 (1.9%) | 8995 / 129020 (7.0%) | −143.8 | −141.3 | 0.27 |
| AR SRX1067070 | LHSAR Prostate | 634 / 12902 (4.9%) | 15029 / 129020 (11.6%) | −143.6 | −141.0 | 0.42 |
| ESR1 SRX20282939 | MCF-7 Breast | 298 / 12902 (2.3%) | 9868 / 129020 (7.6%) | −143.4 | −140.9 | 0.30 |
| Epitope tags SRX10549776 | K-562 Blood | 1060 / 12902 (8.2%) | 4111 / 129020 (3.2%) | −143.3 | −140.7 | 2.58 |
| BRPF3 SRX796086 | RKO Digestive tract | 1120 / 12902 (8.7%) | 4503 / 129020 (3.5%) | −142.4 | −139.8 | 2.49 |
| ESR1 SRX371467 | MCF-7 Breast | 272 / 12902 (2.1%) | 9383 / 129020 (7.3%) | −141.8 | −139.3 | 0.29 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 377 / 12902 (2.9%) | 11099 / 129020 (8.6%) | −141.7 | −139.2 | 0.34 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 220 / 12902 (1.7%) | 117 / 129020 (0.1%) | −141.4 | −138.9 | 18.80 |
| ESR1 SRX20282954 | MCF-7 Breast | 285 / 12902 (2.2%) | 9561 / 129020 (7.4%) | −140.6 | −138.1 | 0.30 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 609 / 12902 (4.7%) | 14549 / 129020 (11.3%) | −140.4 | −137.9 | 0.42 |
| ESR1 SRX371470 | ZR-75-1 Breast | 237 / 12902 (1.8%) | 8733 / 129020 (6.8%) | −140.4 | −137.9 | 0.27 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 903 / 12902 (7.0%) | 3206 / 129020 (2.5%) | −140.3 | −137.8 | 2.82 |
| RELA SRX2207673 | HUVEC Cardiovascular | 955 / 12902 (7.4%) | 19325 / 129020 (15.0%) | −140.2 | −137.7 | 0.49 |
| ESR1 SRX194569 | MCF-7 Breast | 275 / 12902 (2.1%) | 9356 / 129020 (7.3%) | −139.4 | −136.9 | 0.29 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 637 / 12902 (4.9%) | 1758 / 129020 (1.4%) | −138.6 | −136.1 | 3.62 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 417 / 12902 (3.2%) | 750 / 129020 (0.6%) | −138.3 | −135.8 | 5.56 |
| STAT5B SRX831881 | CD8+ T cells Blood | 211 / 12902 (1.6%) | 110 / 129020 (0.1%) | −136.6 | −134.1 | 19.18 |
| ESR1 SRX20282972 | MCF-7 Breast | 300 / 12902 (2.3%) | 9644 / 129020 (7.5%) | −135.5 | −133.0 | 0.31 |
| AGO2 SRX6783957 | Hep G2 Liver | 944 / 12902 (7.3%) | 3528 / 129020 (2.7%) | −135.3 | −132.8 | 2.68 |
| FOS SRX150517 | MCF 10A Breast | 458 / 12902 (3.5%) | 12117 / 129020 (9.4%) | −135.0 | −132.5 | 0.38 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 256 / 12902 (2.0%) | 8883 / 129020 (6.9%) | −134.8 | −132.3 | 0.29 |
| ESR1 SRX10365535 | MCF-7 Breast | 205 / 12902 (1.6%) | 7989 / 129020 (6.2%) | −134.8 | −132.3 | 0.26 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 637 / 12902 (4.9%) | 14716 / 129020 (11.4%) | −134.3 | −131.8 | 0.43 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 346 / 12902 (2.7%) | 10341 / 129020 (8.0%) | −134.0 | −131.5 | 0.33 |
| ESR1 SRX20282955 | MCF-7 Breast | 280 / 12902 (2.2%) | 9245 / 129020 (7.2%) | −133.6 | −131.1 | 0.30 |
| ESR1 SRX194572 | MCF-7 Breast | 163 / 12902 (1.3%) | 7166 / 129020 (5.6%) | −133.0 | −130.5 | 0.23 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 599 / 12902 (4.6%) | 14116 / 129020 (10.9%) | −132.8 | −130.4 | 0.42 |
| FOXA1 SRX1161173 | MCF-7 Breast | 211 / 12902 (1.6%) | 8036 / 129020 (6.2%) | −132.8 | −130.3 | 0.26 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 652 / 12902 (5.1%) | 14868 / 129020 (11.5%) | −132.7 | −130.2 | 0.44 |
| FOXA2 SRX3230382 | Hep G2 Liver | 364 / 12902 (2.8%) | 10581 / 129020 (8.2%) | −132.7 | −130.2 | 0.34 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 244 / 12902 (1.9%) | 8601 / 129020 (6.7%) | −132.5 | −130.0 | 0.28 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 241 / 12902 (1.9%) | 8548 / 129020 (6.6%) | −132.3 | −129.9 | 0.28 |
| FOXA1 SRX1161175 | MCF-7 Breast | 196 / 12902 (1.5%) | 7742 / 129020 (6.0%) | −132.0 | −129.6 | 0.25 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 247 / 12902 (1.9%) | 8639 / 129020 (6.7%) | −131.9 | −129.5 | 0.29 |
| ESR1 SRX371468 | MCF-7 Breast | 167 / 12902 (1.3%) | 7208 / 129020 (5.6%) | −131.9 | −129.4 | 0.23 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 265 / 12902 (2.1%) | 8914 / 129020 (6.9%) | −131.1 | −128.7 | 0.30 |
| FOXA1 SRX1161174 | MCF-7 Breast | 279 / 12902 (2.2%) | 9129 / 129020 (7.1%) | −130.4 | −128.0 | 0.31 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1056 / 12902 (8.2%) | 20229 / 129020 (15.7%) | −130.4 | −127.9 | 0.52 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1047 / 12902 (8.1%) | 4252 / 129020 (3.3%) | −130.3 | −127.9 | 2.46 |
| FOXA1 SRX100454 | T-47D Breast | 359 / 12902 (2.8%) | 10412 / 129020 (8.1%) | −130.1 | −127.6 | 0.34 |
| ESR1 SRX20282940 | MCF-7 Breast | 295 / 12902 (2.3%) | 9378 / 129020 (7.3%) | −130.0 | −127.6 | 0.31 |
| CEBPB SRX150632 | HeLa Uterus | 620 / 12902 (4.8%) | 14306 / 129020 (11.1%) | −130.0 | −127.6 | 0.43 |
| GATA3 SRX176864 | MCF-7 Breast | 197 / 12902 (1.5%) | 7660 / 129020 (5.9%) | −128.6 | −126.2 | 0.26 |
| AGO2 SRX6783958 | Hep G2 Liver | 910 / 12902 (7.1%) | 3430 / 129020 (2.7%) | −128.3 | −125.9 | 2.65 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 926 / 12902 (7.2%) | 18435 / 129020 (14.3%) | −128.3 | −125.9 | 0.50 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 476 / 12902 (3.7%) | 1081 / 129020 (0.8%) | −127.8 | −125.4 | 4.40 |
| SS18 SRX3468047 | Fibroblasts Others | 694 / 12902 (5.4%) | 15262 / 129020 (11.8%) | −127.8 | −125.4 | 0.45 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 698 / 12902 (5.4%) | 2210 / 129020 (1.7%) | −127.5 | −125.2 | 3.16 |
| YAP1 SRX5718140 | 293 Kidney | 462 / 12902 (3.6%) | 11903 / 129020 (9.2%) | −127.4 | −125.0 | 0.39 |
| ESR1 SRX20282973 | MCF-7 Breast | 335 / 12902 (2.6%) | 9936 / 129020 (7.7%) | −127.3 | −124.9 | 0.34 |
| FOS SRX150476 | MCF 10A Breast | 484 / 12902 (3.8%) | 12208 / 129020 (9.5%) | −126.8 | −124.4 | 0.40 |
| ING5 SRX286202 | RKO Digestive tract | 1004 / 12902 (7.8%) | 4043 / 129020 (3.1%) | −126.6 | −124.2 | 2.48 |
| FOXA1 SRX371480 | MCF-7 Breast | 184 / 12902 (1.4%) | 7358 / 129020 (5.7%) | −126.4 | −124.1 | 0.25 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 345 / 12902 (2.7%) | 546 / 129020 (0.4%) | −126.4 | −124.0 | 6.32 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 535 / 12902 (4.1%) | 12942 / 129020 (10.0%) | −126.3 | −123.9 | 0.41 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 636 / 12902 (4.9%) | 1892 / 129020 (1.5%) | −126.1 | −123.7 | 3.36 |
| TP53 SRX396254 | Fibroblasts Others | 682 / 12902 (5.3%) | 2147 / 129020 (1.7%) | −125.5 | −123.2 | 3.18 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 217 / 12902 (1.7%) | 7900 / 129020 (6.1%) | −125.1 | −122.8 | 0.27 |
| CEBPA SRX2630241 | Hep G2 Liver | 333 / 12902 (2.6%) | 9824 / 129020 (7.6%) | −124.9 | −122.6 | 0.34 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 355 / 12902 (2.8%) | 10152 / 129020 (7.9%) | −124.3 | −122.0 | 0.35 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 248 / 12902 (1.9%) | 8401 / 129020 (6.5%) | −124.1 | −121.8 | 0.30 |
| FOXA1 SRX1787653 | MCF-7 Breast | 223 / 12902 (1.7%) | 7969 / 129020 (6.2%) | −124.0 | −121.7 | 0.28 |
| RUNX1 SRX2513054 | 293 Kidney | 2333 / 12902 (18.1%) | 13767 / 129020 (10.7%) | −123.9 | −121.5 | 1.69 |
| TP53 SRX19538272 | U2OS Bone | 434 / 12902 (3.4%) | 926 / 129020 (0.7%) | −123.8 | −121.4 | 4.69 |
| ESR1 SRX20282971 | MCF-7 Breast | 273 / 12902 (2.1%) | 8806 / 129020 (6.8%) | −123.6 | −121.3 | 0.31 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 480 / 12902 (3.7%) | 1136 / 129020 (0.9%) | −123.6 | −121.3 | 4.23 |
| JUNB SRX8488088 | SUM 229PE Breast | 547 / 12902 (4.2%) | 13003 / 129020 (10.1%) | −123.3 | −121.0 | 0.42 |
| ESR1 SRX2881002 | MCF-7 Breast | 265 / 12902 (2.1%) | 8647 / 129020 (6.7%) | −123.0 | −120.6 | 0.31 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1509 / 12902 (11.7%) | 7565 / 129020 (5.9%) | −122.3 | −119.9 | 1.99 |
| FOXA1 SRX11222441 | MCF-7 Breast | 210 / 12902 (1.6%) | 7687 / 129020 (6.0%) | −122.3 | −119.9 | 0.27 |
| ESR1 SRX371476 | MCF-7 Breast | 214 / 12902 (1.7%) | 7752 / 129020 (6.0%) | −122.1 | −119.7 | 0.28 |
| VGLL1 SRX24602130 | BT-20 Breast | 295 / 12902 (2.3%) | 9109 / 129020 (7.1%) | −122.0 | −119.7 | 0.32 |
| ESR1 SRX2881000 | MCF-7 Breast | 246 / 12902 (1.9%) | 8295 / 129020 (6.4%) | −121.9 | −119.6 | 0.30 |
| FOXA1 SRX100506 | Hep G2 Liver | 380 / 12902 (2.9%) | 10451 / 129020 (8.1%) | −121.8 | −119.5 | 0.36 |
| GATA3 SRX5057632 | MCF-7 Breast | 186 / 12902 (1.4%) | 7234 / 129020 (5.6%) | −121.3 | −119.0 | 0.26 |
| FOXA1 SRX3923514 | MCF-7 Breast | 288 / 12902 (2.2%) | 8969 / 129020 (7.0%) | −121.3 | −118.9 | 0.32 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 235 / 12902 (1.8%) | 8089 / 129020 (6.3%) | −121.3 | −118.9 | 0.29 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 198 / 12902 (1.5%) | 7444 / 129020 (5.8%) | −121.2 | −118.9 | 0.27 |
| RAC1 SRX10365543 | MCF-7 Breast | 143 / 12902 (1.1%) | 6425 / 129020 (5.0%) | −120.8 | −118.5 | 0.22 |
| JUN SRX17561461 | LPS141 Adipocyte | 416 / 12902 (3.2%) | 10952 / 129020 (8.5%) | −120.3 | −118.0 | 0.38 |
| AR SRX10820651 | LNCAP Prostate | 256 / 12902 (2.0%) | 277 / 129020 (0.2%) | −120.0 | −117.7 | 9.24 |
| AR SRX9109110 | MDA-MB-453 Breast | 545 / 12902 (4.2%) | 12819 / 129020 (9.9%) | −119.4 | −117.1 | 0.43 |
| ESR1 SRX10365536 | MCF-7 Breast | 146 / 12902 (1.1%) | 6439 / 129020 (5.0%) | −119.3 | −117.0 | 0.23 |
| FOXA1 SRX11222442 | MCF-7 Breast | 184 / 12902 (1.4%) | 7126 / 129020 (5.5%) | −119.0 | −116.8 | 0.26 |
| NR2F2 SRX190293 | MCF-7 Breast | 298 / 12902 (2.3%) | 9052 / 129020 (7.0%) | −118.9 | −116.6 | 0.33 |
| ARID1A SRX5089376 | MCF-7 Breast | 246 / 12902 (1.9%) | 8192 / 129020 (6.3%) | −118.8 | −116.5 | 0.30 |
| RAC1 SRX10365541 | MCF-7 Breast | 147 / 12902 (1.1%) | 6441 / 129020 (5.0%) | −118.8 | −116.5 | 0.23 |
| ESR1 SRX20282953 | MCF-7 Breast | 235 / 12902 (1.8%) | 8002 / 129020 (6.2%) | −118.7 | −116.4 | 0.29 |
| TEAD1 SRX3401272 | MCF-7 Breast | 215 / 12902 (1.7%) | 7647 / 129020 (5.9%) | −118.3 | −116.0 | 0.28 |
| GATAD2A SRX2636506 | Hep G2 Liver | 368 / 12902 (2.9%) | 10137 / 129020 (7.9%) | −118.2 | −115.9 | 0.36 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 313 / 12902 (2.4%) | 9261 / 129020 (7.2%) | −117.9 | −115.7 | 0.34 |
| ESR1 SRX20282938 | MCF-7 Breast | 227 / 12902 (1.8%) | 7827 / 129020 (6.1%) | −117.4 | −115.1 | 0.29 |
| FOXA2 SRX100448 | Hep G2 Liver | 324 / 12902 (2.5%) | 9419 / 129020 (7.3%) | −117.3 | −115.1 | 0.34 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 478 / 12902 (3.7%) | 11764 / 129020 (9.1%) | −117.3 | −115.0 | 0.41 |
| SSRP1 SRX3436567 | HT-1080 Bone | 303 / 12902 (2.3%) | 445 / 129020 (0.3%) | −117.2 | −114.9 | 6.81 |
| ARID5B SRX3230377 | Hep G2 Liver | 730 / 12902 (5.7%) | 15326 / 129020 (11.9%) | −117.2 | −114.9 | 0.48 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 135 / 12902 (1.0%) | 6152 / 129020 (4.8%) | −116.8 | −114.5 | 0.22 |
| FOXA1 SRX1787652 | MCF-7 Breast | 168 / 12902 (1.3%) | 6765 / 129020 (5.2%) | −116.8 | −114.5 | 0.25 |
| ESR1 SRX5323873 | MCF-7 Breast | 357 / 12902 (2.8%) | 9896 / 129020 (7.7%) | −116.3 | −114.0 | 0.36 |
| FOXA1 SRX11222437 | MCF-7 Breast | 206 / 12902 (1.6%) | 7423 / 129020 (5.8%) | −116.2 | −113.9 | 0.28 |
| TCF12 SRX190356 | SK-N-SH Neural | 784 / 12902 (6.1%) | 16014 / 129020 (12.4%) | −116.1 | −113.8 | 0.49 |
| FOXA1 SRX3931043 | MCF-7 Breast | 301 / 12902 (2.3%) | 9002 / 129020 (7.0%) | −116.0 | −113.7 | 0.33 |
| ESR1 SRX2943591 | MCF-7 Breast | 203 / 12902 (1.6%) | 7359 / 129020 (5.7%) | −115.7 | −113.5 | 0.28 |
| TFAP2C SRX018833 | MCF-7 Breast | 258 / 12902 (2.0%) | 8287 / 129020 (6.4%) | −115.5 | −113.3 | 0.31 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 958 / 12902 (7.4%) | 18290 / 129020 (14.2%) | −115.4 | −113.1 | 0.52 |
| ESR1 SRX20282946 | MCF-7 Breast | 172 / 12902 (1.3%) | 6788 / 129020 (5.3%) | −115.2 | −112.9 | 0.25 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 197 / 12902 (1.5%) | 7233 / 129020 (5.6%) | −115.1 | −112.9 | 0.27 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 224 / 12902 (1.7%) | 7700 / 129020 (6.0%) | −115.0 | −112.8 | 0.29 |
| STAT3 SRX150479 | MCF 10A Breast | 266 / 12902 (2.1%) | 8399 / 129020 (6.5%) | −114.9 | −112.7 | 0.32 |
| TFAP2C SRX128099 | MCF-7 Breast | 259 / 12902 (2.0%) | 8277 / 129020 (6.4%) | −114.8 | −112.6 | 0.31 |
| AR SRX9109113 | MDA-MB-453 Breast | 566 / 12902 (4.4%) | 12933 / 129020 (10.0%) | −114.6 | −112.3 | 0.44 |
| SMARCA4 SRX5212366 | Mel270 Others | 394 / 12902 (3.1%) | 10406 / 129020 (8.1%) | −114.6 | −112.3 | 0.38 |
| FOXA1 SRX1161203 | T-47D Breast | 208 / 12902 (1.6%) | 7400 / 129020 (5.7%) | −114.4 | −112.2 | 0.28 |
| STAT3 SRX2020842 | HCC70 Breast | 525 / 12902 (4.1%) | 12326 / 129020 (9.6%) | −114.1 | −111.9 | 0.43 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 276 / 12902 (2.1%) | 8535 / 129020 (6.6%) | −114.1 | −111.9 | 0.32 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 302 / 12902 (2.3%) | 8953 / 129020 (6.9%) | −114.1 | −111.9 | 0.34 |
| FOXA1 SRX028634 | MCF-7 Breast | 136 / 12902 (1.1%) | 6085 / 129020 (4.7%) | −114.0 | −111.7 | 0.22 |
| FOXA1 SRX5323843 | MCF-7 Breast | 143 / 12902 (1.1%) | 6213 / 129020 (4.8%) | −113.8 | −111.6 | 0.23 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 510 / 12902 (4.0%) | 12096 / 129020 (9.4%) | −113.8 | −111.6 | 0.42 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 871 / 12902 (6.8%) | 17055 / 129020 (13.2%) | −113.2 | −111.0 | 0.51 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 770 / 12902 (6.0%) | 15703 / 129020 (12.2%) | −113.2 | −111.0 | 0.49 |
| JUNB SRX10119386 | MCF 10A Breast | 267 / 12902 (2.1%) | 8335 / 129020 (6.5%) | −112.6 | −110.4 | 0.32 |
| ESR1 SRX8537722 | MCF-7 Breast | 275 / 12902 (2.1%) | 8457 / 129020 (6.6%) | −112.3 | −110.1 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 145 / 12902 (1.1%) | 6202 / 129020 (4.8%) | −112.1 | −109.9 | 0.23 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 585 / 12902 (4.5%) | 1786 / 129020 (1.4%) | −112.0 | −109.8 | 3.28 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 336 / 12902 (2.6%) | 602 / 129020 (0.5%) | −111.7 | −109.5 | 5.58 |
| KMT2A SRX2323891 | 293 Kidney | 731 / 12902 (5.7%) | 2615 / 129020 (2.0%) | −111.7 | −109.5 | 2.80 |
| LEO1 SRX1873456 | SEM Blood | 1060 / 12902 (8.2%) | 4694 / 129020 (3.6%) | −111.5 | −109.3 | 2.26 |
| JUNB SRX8488073 | SUM 229PE Breast | 556 / 12902 (4.3%) | 12669 / 129020 (9.8%) | −111.4 | −109.2 | 0.44 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 399 / 12902 (3.1%) | 10365 / 129020 (8.0%) | −111.4 | −109.2 | 0.38 |
| GATA3 SRX6712581 | MCF-7 Breast | 244 / 12902 (1.9%) | 7908 / 129020 (6.1%) | −111.2 | −109.0 | 0.31 |
| PROX1 SRX3230397 | Hep G2 Liver | 212 / 12902 (1.6%) | 7368 / 129020 (5.7%) | −111.2 | −109.0 | 0.29 |
| STAT3 SRX150630 | MCF 10A Breast | 271 / 12902 (2.1%) | 8353 / 129020 (6.5%) | −111.1 | −108.9 | 0.32 |
| FOXA1 SRX028635 | MCF-7 Breast | 144 / 12902 (1.1%) | 6143 / 129020 (4.8%) | −110.9 | −108.7 | 0.23 |
| ESR1 SRX330067 | MCF-7 Breast | 274 / 12902 (2.1%) | 8388 / 129020 (6.5%) | −110.8 | −108.6 | 0.33 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 288 / 12902 (2.2%) | 8607 / 129020 (6.7%) | −110.5 | −108.3 | 0.33 |
| MEAF6 DRX234811 | 293 Kidney | 1229 / 12902 (9.5%) | 5872 / 129020 (4.6%) | −110.3 | −108.1 | 2.09 |
| FOXA1 SRX3931054 | MCF-7 Breast | 286 / 12902 (2.2%) | 8561 / 129020 (6.6%) | −110.1 | −107.9 | 0.33 |
| SMARCA4 SRX5212362 | Mel270 Others | 516 / 12902 (4.0%) | 12039 / 129020 (9.3%) | −110.1 | −107.9 | 0.43 |
| GATA3 SRX5457550 | MCF-7 Breast | 334 / 12902 (2.6%) | 9319 / 129020 (7.2%) | −110.1 | −107.9 | 0.36 |
| CEBPB SRX190345 | MCF-7 Breast | 227 / 12902 (1.8%) | 7582 / 129020 (5.9%) | −110.0 | −107.8 | 0.30 |
| WWTR1 SRX10119367 | MCF 10A Breast | 348 / 12902 (2.7%) | 9532 / 129020 (7.4%) | −110.0 | −107.8 | 0.37 |
| ESR1 SRX10365558 | MCF-7 Breast | 204 / 12902 (1.6%) | 7189 / 129020 (5.6%) | −109.9 | −107.8 | 0.28 |
| FOXA1 SRX15430999 | T-47D Breast | 340 / 12902 (2.6%) | 9402 / 129020 (7.3%) | −109.8 | −107.7 | 0.36 |
| GATA3 SRX190194 | SK-N-SH Neural | 708 / 12902 (5.5%) | 14714 / 129020 (11.4%) | −109.8 | −107.6 | 0.48 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 500 / 12902 (3.9%) | 1367 / 129020 (1.1%) | −109.7 | −107.6 | 3.66 |
| MEAF6 DRX300417 | 293 Kidney | 1125 / 12902 (8.7%) | 5171 / 129020 (4.0%) | −109.6 | −107.4 | 2.18 |
| ESR1 SRX330070 | MCF-7 Breast | 152 / 12902 (1.2%) | 6250 / 129020 (4.8%) | −109.5 | −107.4 | 0.24 |
| PGR SRX1012655 | MCF-7 Breast | 189 / 12902 (1.5%) | 6902 / 129020 (5.3%) | −109.1 | −107.0 | 0.27 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 681 / 12902 (5.3%) | 14319 / 129020 (11.1%) | −109.1 | −107.0 | 0.48 |
| ARID1A SRX5089379 | MCF-7 Breast | 299 / 12902 (2.3%) | 8731 / 129020 (6.8%) | −109.1 | −106.9 | 0.34 |
| FOS SRX4192879 | MCF 10A Breast | 351 / 12902 (2.7%) | 9532 / 129020 (7.4%) | −108.7 | −106.5 | 0.37 |
| FOXA1 SRX1787651 | MCF-7 Breast | 167 / 12902 (1.3%) | 6495 / 129020 (5.0%) | −108.5 | −106.4 | 0.26 |
| Epitope tags DRX443510 | 293 Kidney | 1065 / 12902 (8.3%) | 4789 / 129020 (3.7%) | −108.5 | −106.4 | 2.22 |
| ESR1 SRX5323871 | MCF-7 Breast | 330 / 12902 (2.6%) | 9200 / 129020 (7.1%) | −108.5 | −106.3 | 0.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 177 / 12902 (1.4%) | 6665 / 129020 (5.2%) | −108.3 | −106.1 | 0.27 |
| JUN SRX4192884 | MCF 10A Breast | 248 / 12902 (1.9%) | 7876 / 129020 (6.1%) | −108.2 | −106.1 | 0.31 |
| HMG20A SRX2630163 | Hep G2 Liver | 166 / 12902 (1.3%) | 6464 / 129020 (5.0%) | −108.2 | −106.0 | 0.26 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 745 / 12902 (5.8%) | 15135 / 129020 (11.7%) | −107.8 | −105.7 | 0.49 |
| NFYB SRX16608147 | HeLa Uterus | 198 / 12902 (1.5%) | 160 / 129020 (0.1%) | −107.8 | −105.6 | 12.38 |
| EP300 SRX176885 | MCF-7 Breast | 153 / 12902 (1.2%) | 6206 / 129020 (4.8%) | −107.5 | −105.4 | 0.25 |
| ESR1 SRX371475 | BT-474 Breast | 158 / 12902 (1.2%) | 6296 / 129020 (4.9%) | −107.5 | −105.4 | 0.25 |
| FOXA1 SRX3931055 | MCF-7 Breast | 261 / 12902 (2.0%) | 8055 / 129020 (6.2%) | −107.3 | −105.2 | 0.32 |
| FOXA1 SRX11222438 | MCF-7 Breast | 161 / 12902 (1.2%) | 6341 / 129020 (4.9%) | −107.2 | −105.0 | 0.25 |
| ESR1 SRX371474 | BT-474 Breast | 142 / 12902 (1.1%) | 5991 / 129020 (4.6%) | −107.1 | −105.0 | 0.24 |
| FOXA1 SRX3923516 | MCF-7 Breast | 219 / 12902 (1.7%) | 7346 / 129020 (5.7%) | −106.8 | −104.7 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 641 / 12902 (5.0%) | 13669 / 129020 (10.6%) | −106.8 | −104.7 | 0.47 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 552 / 12902 (4.3%) | 1671 / 129020 (1.3%) | −106.8 | −104.7 | 3.30 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1248 / 12902 (9.7%) | 6088 / 129020 (4.7%) | −106.8 | −104.7 | 2.05 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 151 / 12902 (1.2%) | 6150 / 129020 (4.8%) | −106.8 | −104.7 | 0.25 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 447 / 12902 (3.5%) | 10907 / 129020 (8.5%) | −106.7 | −104.6 | 0.41 |
| FOXA1 SRX1787655 | MCF-7 Breast | 148 / 12902 (1.1%) | 6089 / 129020 (4.7%) | −106.7 | −104.6 | 0.24 |
| FOXA1 SRX1447317 | MCF-7 Breast | 198 / 12902 (1.5%) | 6979 / 129020 (5.4%) | −106.6 | −104.5 | 0.28 |
| ESR1 SRX10365533 | MCF-7 Breast | 143 / 12902 (1.1%) | 5992 / 129020 (4.6%) | −106.5 | −104.4 | 0.24 |
| JUN SRX6582171 | GM07492 Others | 587 / 12902 (4.5%) | 12904 / 129020 (10.0%) | −106.4 | −104.3 | 0.45 |
| TLE3 SRX4815192 | MCF-7 Breast | 285 / 12902 (2.2%) | 8413 / 129020 (6.5%) | −106.3 | −104.2 | 0.34 |
| ARID5B SRX10475139 | Hep G2 Liver | 337 / 12902 (2.6%) | 9225 / 129020 (7.2%) | −106.1 | −104.0 | 0.37 |
| SOX13 SRX2636248 | Hep G2 Liver | 426 / 12902 (3.3%) | 10572 / 129020 (8.2%) | −106.1 | −104.0 | 0.40 |
| ESR1 SRX11120903 | MCF-7 Breast | 271 / 12902 (2.1%) | 8176 / 129020 (6.3%) | −106.1 | −104.0 | 0.33 |
| SMARCA2 SRX8119677 | MeT-5A Others | 497 / 12902 (3.9%) | 11596 / 129020 (9.0%) | −105.8 | −103.7 | 0.43 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 289 / 12902 (2.2%) | 8446 / 129020 (6.5%) | −105.5 | −103.4 | 0.34 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 954 / 12902 (7.4%) | 17792 / 129020 (13.8%) | −105.5 | −103.4 | 0.54 |
| ESR1 SRX2943589 | MCF-7 Breast | 158 / 12902 (1.2%) | 6232 / 129020 (4.8%) | −105.4 | −103.3 | 0.25 |
| ESR1 SRX330069 | MCF-7 Breast | 191 / 12902 (1.5%) | 6815 / 129020 (5.3%) | −105.3 | −103.2 | 0.28 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 585 / 12902 (4.5%) | 12829 / 129020 (9.9%) | −105.3 | −103.2 | 0.46 |
| NKX2-1 SRX2164786 | A549 Lung | 503 / 12902 (3.9%) | 11645 / 129020 (9.0%) | −104.8 | −102.7 | 0.43 |
| CDK9 SRX7366783 | MCF-7 Breast | 183 / 12902 (1.4%) | 132 / 129020 (0.1%) | −104.8 | −102.7 | 13.86 |
| STAT3 SRX150536 | MCF 10A Breast | 350 / 12902 (2.7%) | 9377 / 129020 (7.3%) | −104.7 | −102.7 | 0.37 |
| ARID5B SRX10475138 | Hep G2 Liver | 517 / 12902 (4.0%) | 11834 / 129020 (9.2%) | −104.5 | −102.4 | 0.44 |
| DAXX SRX1021630 | PC-3 Prostate | 311 / 12902 (2.4%) | 8758 / 129020 (6.8%) | −104.5 | −102.4 | 0.36 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 566 / 12902 (4.4%) | 12527 / 129020 (9.7%) | −104.4 | −102.3 | 0.45 |
| FOXA1 SRX100477 | Hep G2 Liver | 362 / 12902 (2.8%) | 9545 / 129020 (7.4%) | −104.3 | −102.3 | 0.38 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 591 / 12902 (4.6%) | 12871 / 129020 (10.0%) | −104.3 | −102.3 | 0.46 |
| ESR1 SRX2513517 | MCF-7 Breast | 211 / 12902 (1.6%) | 7123 / 129020 (5.5%) | −104.3 | −102.2 | 0.30 |
| AR SRX1067067 | LHSAR Prostate | 525 / 12902 (4.1%) | 11940 / 129020 (9.3%) | −104.3 | −102.2 | 0.44 |
| FOXA1 SRX5323829 | T-47D Breast | 174 / 12902 (1.3%) | 6476 / 129020 (5.0%) | −104.1 | −102.0 | 0.27 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 393 / 12902 (3.0%) | 905 / 129020 (0.7%) | −104.0 | −101.9 | 4.34 |
| AR SRX9469988 | LAPC-4 Prostate | 416 / 12902 (3.2%) | 10342 / 129020 (8.0%) | −104.0 | −101.9 | 0.40 |
| FOXA1 SRX3923517 | MCF-7 Breast | 221 / 12902 (1.7%) | 7284 / 129020 (5.6%) | −104.0 | −101.9 | 0.30 |
| ESR1 SRX10365532 | MCF-7 Breast | 168 / 12902 (1.3%) | 6369 / 129020 (4.9%) | −104.0 | −101.9 | 0.26 |
| SMARCA4 SRX5212357 | Mel270 Others | 450 / 12902 (3.5%) | 10841 / 129020 (8.4%) | −103.9 | −101.9 | 0.42 |
| ESR1 SRX1012629 | MCF-7 Breast | 198 / 12902 (1.5%) | 6884 / 129020 (5.3%) | −103.7 | −101.7 | 0.29 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1058 / 12902 (8.2%) | 19039 / 129020 (14.8%) | −103.7 | −101.6 | 0.56 |
| ESR1 SRX2912055 | MCF-7 Breast | 119 / 12902 (0.9%) | 5449 / 129020 (4.2%) | −103.5 | −101.5 | 0.22 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1132 / 12902 (8.8%) | 5356 / 129020 (4.2%) | −103.4 | −101.4 | 2.11 |
| ESR1 SRX5323878 | MCF-7 Breast | 315 / 12902 (2.4%) | 8782 / 129020 (6.8%) | −103.3 | −101.2 | 0.36 |
| ESR1 SRX1012632 | MCF-7 Breast | 156 / 12902 (1.2%) | 6128 / 129020 (4.7%) | −103.2 | −101.2 | 0.25 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 210 / 12902 (1.6%) | 7067 / 129020 (5.5%) | −103.0 | −101.0 | 0.30 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 305 / 12902 (2.4%) | 8607 / 129020 (6.7%) | −102.9 | −100.8 | 0.35 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 283 / 12902 (2.2%) | 8259 / 129020 (6.4%) | −102.8 | −100.8 | 0.34 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 259 / 12902 (2.0%) | 7867 / 129020 (6.1%) | −102.7 | −100.6 | 0.33 |
| FOXA1 SRX1961158 | T-47D Breast | 317 / 12902 (2.5%) | 8776 / 129020 (6.8%) | −102.4 | −100.3 | 0.36 |
| AR SRX1067066 | LHSAR Prostate | 645 / 12902 (5.0%) | 13537 / 129020 (10.5%) | −102.3 | −100.3 | 0.48 |
| ZEB1 SRX13298924 | MCF-7 Breast | 143 / 12902 (1.1%) | 5861 / 129020 (4.5%) | −102.3 | −100.3 | 0.24 |
| EP300 SRX2671813 | Fibroblasts Others | 265 / 12902 (2.1%) | 7945 / 129020 (6.2%) | −102.2 | −100.1 | 0.33 |
| ESR1 SRX1469949 | MCF-7 Breast | 182 / 12902 (1.4%) | 6553 / 129020 (5.1%) | −102.1 | −100.1 | 0.28 |
| GATAD2A SRX2636507 | Hep G2 Liver | 340 / 12902 (2.6%) | 9122 / 129020 (7.1%) | −102.1 | −100.0 | 0.37 |
| EP300 SRX1012648 | MCF-7 Breast | 148 / 12902 (1.1%) | 5942 / 129020 (4.6%) | −102.0 | −99.9 | 0.25 |
| Epitope tags SRX5877912 | U2OS Bone | 1705 / 12902 (13.2%) | 26843 / 129020 (20.8%) | −101.3 | −99.3 | 0.64 |
| SMARCA4 SRX5212371 | Mel270 Others | 443 / 12902 (3.4%) | 10639 / 129020 (8.2%) | −101.3 | −99.3 | 0.42 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 302 / 12902 (2.3%) | 8498 / 129020 (6.6%) | −101.2 | −99.1 | 0.36 |
| ESR1 SRX2513520 | MCF-7 Breast | 199 / 12902 (1.5%) | 6816 / 129020 (5.3%) | −101.2 | −99.1 | 0.29 |
| PBX3 SRX190343 | SK-N-SH Neural | 642 / 12902 (5.0%) | 13448 / 129020 (10.4%) | −101.1 | −99.1 | 0.48 |
| ESR1 SRX4451213 | MCF-7 Breast | 325 / 12902 (2.5%) | 8854 / 129020 (6.9%) | −101.1 | −99.1 | 0.37 |
| ESR1 SRX8537723 | MCF-7 Breast | 256 / 12902 (2.0%) | 7756 / 129020 (6.0%) | −100.9 | −98.9 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 126 / 12902 (1.0%) | 5506 / 129020 (4.3%) | −100.9 | −98.9 | 0.23 |
| ESR1 SRX3110725 | MCF-7 Breast | 290 / 12902 (2.2%) | 8302 / 129020 (6.4%) | −100.9 | −98.9 | 0.35 |
| FOXA2 SRX10475773 | Hep G2 Liver | 390 / 12902 (3.0%) | 9836 / 129020 (7.6%) | −100.9 | −98.8 | 0.40 |
| ESR1 SRX5323872 | MCF-7 Breast | 318 / 12902 (2.5%) | 8739 / 129020 (6.8%) | −100.8 | −98.8 | 0.36 |
| FOXA1 SRX3923518 | MCF-7 Breast | 221 / 12902 (1.7%) | 7171 / 129020 (5.6%) | −100.6 | −98.6 | 0.31 |
| FOXA1 SRX3923519 | MCF-7 Breast | 195 / 12902 (1.5%) | 6731 / 129020 (5.2%) | −100.6 | −98.6 | 0.29 |
| CDK9 SRX7366781 | MCF-7 Breast | 176 / 12902 (1.4%) | 128 / 129020 (0.1%) | −100.4 | −98.4 | 13.75 |
| ESR1 SRX1012633 | MCF-7 Breast | 164 / 12902 (1.3%) | 6182 / 129020 (4.8%) | −100.4 | −98.4 | 0.27 |
| FOXA1 SRX3931033 | MCF-7 Breast | 203 / 12902 (1.6%) | 6857 / 129020 (5.3%) | −100.3 | −98.3 | 0.30 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 218 / 12902 (1.7%) | 7110 / 129020 (5.5%) | −100.3 | −98.3 | 0.31 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 462 / 12902 (3.6%) | 10877 / 129020 (8.4%) | −100.3 | −98.3 | 0.42 |
| ESR1 SRX3123829 | MCF-7 Breast | 186 / 12902 (1.4%) | 6564 / 129020 (5.1%) | −100.2 | −98.2 | 0.28 |
| ESR1 SRX20282959 | MCF-7 Breast | 132 / 12902 (1.0%) | 5588 / 129020 (4.3%) | −100.0 | −98.0 | 0.24 |
| NFIL3 SRX2630334 | Hep G2 Liver | 256 / 12902 (2.0%) | 7721 / 129020 (6.0%) | −99.8 | −97.8 | 0.33 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 302 / 12902 (2.3%) | 8442 / 129020 (6.5%) | −99.6 | −97.6 | 0.36 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 307 / 12902 (2.4%) | 8524 / 129020 (6.6%) | −99.6 | −97.6 | 0.36 |
| FOS SRX3322636 | MCF-7 Breast | 206 / 12902 (1.6%) | 6883 / 129020 (5.3%) | −99.5 | −97.5 | 0.30 |
| ARID1A SRX5089391 | MCF-7 Breast | 176 / 12902 (1.4%) | 6360 / 129020 (4.9%) | −99.4 | −97.4 | 0.28 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 415 / 12902 (3.2%) | 1053 / 129020 (0.8%) | −99.1 | −97.1 | 3.94 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1251 / 12902 (9.7%) | 6300 / 129020 (4.9%) | −99.0 | −97.0 | 1.99 |
| FOXA1 SRX3923515 | MCF-7 Breast | 181 / 12902 (1.4%) | 6433 / 129020 (5.0%) | −98.9 | −96.9 | 0.28 |
| SOX5 SRX2636544 | Hep G2 Liver | 324 / 12902 (2.5%) | 8760 / 129020 (6.8%) | −98.9 | −96.9 | 0.37 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 304 / 12902 (2.4%) | 8442 / 129020 (6.5%) | −98.7 | −96.7 | 0.36 |
| ESR1 SRX2513521 | MCF-7 Breast | 153 / 12902 (1.2%) | 5927 / 129020 (4.6%) | −98.6 | −96.6 | 0.26 |
| ESR1 SRX4451212 | MCF-7 Breast | 309 / 12902 (2.4%) | 8514 / 129020 (6.6%) | −98.5 | −96.5 | 0.36 |
| CIC SRX13262055 | Astrocytes Neural | 2109 / 12902 (16.3%) | 12869 / 129020 (10.0%) | −98.5 | −96.5 | 1.64 |
| GATA3 SRX100559 | T-47D Breast | 357 / 12902 (2.8%) | 9252 / 129020 (7.2%) | −98.5 | −96.5 | 0.39 |
| AR SRX9109109 | MDA-MB-453 Breast | 376 / 12902 (2.9%) | 9530 / 129020 (7.4%) | −98.2 | −96.3 | 0.39 |
| ESR1 SRX5323877 | MCF-7 Breast | 255 / 12902 (2.0%) | 7648 / 129020 (5.9%) | −98.2 | −96.2 | 0.33 |
| FOXA1 SRX5323845 | MCF-7 Breast | 115 / 12902 (0.9%) | 5211 / 129020 (4.0%) | −98.2 | −96.2 | 0.22 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 450 / 12902 (3.5%) | 10616 / 129020 (8.2%) | −98.1 | −96.2 | 0.42 |
| FOXA1 SRX5203303 | MCF-7 Breast | 108 / 12902 (0.8%) | 5072 / 129020 (3.9%) | −98.1 | −96.1 | 0.21 |
| FOXA1 SRX1447316 | MCF-7 Breast | 136 / 12902 (1.1%) | 5604 / 129020 (4.3%) | −98.1 | −96.1 | 0.24 |
| SP1 SRX5457499 | Liver Liver | 553 / 12902 (4.3%) | 12080 / 129020 (9.4%) | −98.0 | −96.0 | 0.46 |
| TEAD3 SRX2636153 | Hep G2 Liver | 766 / 12902 (5.9%) | 14984 / 129020 (11.6%) | −98.0 | −96.0 | 0.51 |
| FOXA1 SRX1961157 | T-47D Breast | 358 / 12902 (2.8%) | 9246 / 129020 (7.2%) | −98.0 | −96.0 | 0.39 |
| FOXA1 SRX1161207 | T-47D Breast | 133 / 12902 (1.0%) | 5540 / 129020 (4.3%) | −97.9 | −95.9 | 0.24 |
| JUN SRX883584 | MDA-MB-231 Breast | 500 / 12902 (3.9%) | 11321 / 129020 (8.8%) | −97.7 | −95.7 | 0.44 |
| ESR1 SRX1469951 | MCF-7 Breast | 170 / 12902 (1.3%) | 6198 / 129020 (4.8%) | −97.5 | −95.5 | 0.27 |
| ESR1 SRX1531796 | MCF-7 Breast | 176 / 12902 (1.4%) | 6287 / 129020 (4.9%) | −97.1 | −95.1 | 0.28 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 354 / 12902 (2.7%) | 9153 / 129020 (7.1%) | −97.1 | −95.1 | 0.39 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 216 / 12902 (1.7%) | 6965 / 129020 (5.4%) | −97.0 | −95.0 | 0.31 |
| EP300 SRX150579 | HeLa Uterus | 213 / 12902 (1.7%) | 6916 / 129020 (5.4%) | −96.9 | −95.0 | 0.31 |
| EP300 SRX176883 | MCF-7 Breast | 154 / 12902 (1.2%) | 5892 / 129020 (4.6%) | −96.9 | −94.9 | 0.26 |
| FOXA1 SRX5323830 | T-47D Breast | 197 / 12902 (1.5%) | 6635 / 129020 (5.1%) | −96.7 | −94.8 | 0.30 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 306 / 12902 (2.4%) | 8400 / 129020 (6.5%) | −96.7 | −94.7 | 0.36 |
| NANOG SRX10445309 | Neural crest cells Neural | 177 / 12902 (1.4%) | 6291 / 129020 (4.9%) | −96.6 | −94.7 | 0.28 |
| RELA SRX5938177 | FaDu Others | 305 / 12902 (2.4%) | 8383 / 129020 (6.5%) | −96.6 | −94.6 | 0.36 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 303 / 12902 (2.3%) | 8351 / 129020 (6.5%) | −96.6 | −94.6 | 0.36 |
| YAP1 SRX10119364 | MCF 10A Breast | 274 / 12902 (2.1%) | 7891 / 129020 (6.1%) | −96.5 | −94.5 | 0.35 |
| Epitope tags SRX15939724 | RD Muscle | 279 / 12902 (2.2%) | 7971 / 129020 (6.2%) | −96.4 | −94.5 | 0.35 |
| JUNB SRX4192882 | MCF 10A Breast | 260 / 12902 (2.0%) | 7664 / 129020 (5.9%) | −96.4 | −94.5 | 0.34 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 557 / 12902 (4.3%) | 12067 / 129020 (9.4%) | −96.3 | −94.3 | 0.46 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 335 / 12902 (2.6%) | 8833 / 129020 (6.8%) | −96.2 | −94.3 | 0.38 |
| EP300 SRX1012644 | MCF-7 Breast | 147 / 12902 (1.1%) | 5739 / 129020 (4.4%) | −96.0 | −94.1 | 0.26 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1009 / 12902 (7.8%) | 4682 / 129020 (3.6%) | −95.8 | −93.8 | 2.16 |
| ARID1A SRX5089388 | MCF-7 Breast | 166 / 12902 (1.3%) | 6067 / 129020 (4.7%) | −95.7 | −93.7 | 0.27 |
| RXRB SRX2636027 | Hep G2 Liver | 355 / 12902 (2.8%) | 9114 / 129020 (7.1%) | −95.7 | −93.7 | 0.39 |
| WWTR1 SRX10119378 | MCF 10A Breast | 350 / 12902 (2.7%) | 9036 / 129020 (7.0%) | −95.6 | −93.7 | 0.39 |
| FOXA1 SRX1161205 | T-47D Breast | 179 / 12902 (1.4%) | 6287 / 129020 (4.9%) | −95.4 | −93.4 | 0.28 |
| FOXA3 SRX2630189 | Hep G2 Liver | 267 / 12902 (2.1%) | 7739 / 129020 (6.0%) | −95.3 | −93.4 | 0.35 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 894 / 12902 (6.9%) | 16533 / 129020 (12.8%) | −95.2 | −93.2 | 0.54 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 124 / 12902 (1.0%) | 5290 / 129020 (4.1%) | −95.1 | −93.2 | 0.23 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 880 / 12902 (6.8%) | 3833 / 129020 (3.0%) | −95.1 | −93.2 | 2.30 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 191 / 12902 (1.5%) | 6481 / 129020 (5.0%) | −95.1 | −93.2 | 0.29 |
| RAD21 SRX2630359 | Liver Liver | 756 / 12902 (5.9%) | 14706 / 129020 (11.4%) | −94.8 | −92.9 | 0.51 |
| PRRX1 SRX15235713 | Hs 578T Breast | 398 / 12902 (3.1%) | 9723 / 129020 (7.5%) | −94.7 | −92.8 | 0.41 |
| JUNB SRX10119383 | MCF 10A Breast | 229 / 12902 (1.8%) | 7097 / 129020 (5.5%) | −94.5 | −92.6 | 0.32 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 332 / 12902 (2.6%) | 8723 / 129020 (6.8%) | −94.5 | −92.6 | 0.38 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 774 / 12902 (6.0%) | 3158 / 129020 (2.4%) | −94.5 | −92.6 | 2.45 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 425 / 12902 (3.3%) | 10099 / 129020 (7.8%) | −94.2 | −92.3 | 0.42 |
| CEBPB SRX2194250 | SUM 159PT Breast | 394 / 12902 (3.1%) | 9639 / 129020 (7.5%) | −94.2 | −92.2 | 0.41 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 234 / 12902 (1.8%) | 7164 / 129020 (5.6%) | −94.0 | −92.1 | 0.33 |
| FOXA1 SRX1787654 | MCF-7 Breast | 121 / 12902 (0.9%) | 5200 / 129020 (4.0%) | −94.0 | −92.1 | 0.23 |
| JUNB SRX8488074 | SUM 229PE Breast | 440 / 12902 (3.4%) | 10304 / 129020 (8.0%) | −93.9 | −91.9 | 0.43 |
| FOXA3 SRX2630190 | Hep G2 Liver | 282 / 12902 (2.2%) | 7921 / 129020 (6.1%) | −93.8 | −91.9 | 0.36 |
| NR3C1 SRX8520802 | HCC1187 Breast | 247 / 12902 (1.9%) | 7365 / 129020 (5.7%) | −93.7 | −91.8 | 0.34 |
| ESR1 SRX2513518 | MCF-7 Breast | 166 / 12902 (1.3%) | 6005 / 129020 (4.7%) | −93.7 | −91.8 | 0.28 |
| Epitope tags SRX10549778 | K-562 Blood | 788 / 12902 (6.1%) | 3265 / 129020 (2.5%) | −93.6 | −91.7 | 2.41 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 492 / 12902 (3.8%) | 11034 / 129020 (8.6%) | −93.5 | −91.6 | 0.45 |
| FOXA1 SRX3923511 | MCF-7 Breast | 131 / 12902 (1.0%) | 5365 / 129020 (4.2%) | −93.4 | −91.5 | 0.24 |
| VGLL1 SRX18013277 | FULVR Breast | 147 / 12902 (1.1%) | 5650 / 129020 (4.4%) | −93.1 | −91.2 | 0.26 |
| EP300 SRX1012643 | MCF-7 Breast | 122 / 12902 (0.9%) | 5190 / 129020 (4.0%) | −93.1 | −91.1 | 0.24 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 91 / 12902 (0.7%) | 4590 / 129020 (3.6%) | −93.0 | −91.1 | 0.20 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 616 / 12902 (4.8%) | 12743 / 129020 (9.9%) | −93.0 | −91.1 | 0.48 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 558 / 12902 (4.3%) | 11933 / 129020 (9.2%) | −92.8 | −90.9 | 0.47 |
| 5-mC SRX882970 | LNCAP Prostate | 1940 / 12902 (15.0%) | 11723 / 129020 (9.1%) | −92.8 | −90.9 | 1.65 |
| ESR1 SRX20282966 | MCF-7 Breast | 120 / 12902 (0.9%) | 5141 / 129020 (4.0%) | −92.8 | −90.9 | 0.23 |
| NR3C1 SRX19024866 | MCF-7 Breast | 117 / 12902 (0.9%) | 5085 / 129020 (3.9%) | −92.7 | −90.8 | 0.23 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 407 / 12902 (3.2%) | 1077 / 129020 (0.8%) | −92.7 | −90.8 | 3.78 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 394 / 12902 (3.1%) | 9575 / 129020 (7.4%) | −92.4 | −90.5 | 0.41 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 637 / 12902 (4.9%) | 12993 / 129020 (10.1%) | −92.2 | −90.3 | 0.49 |
| FOXA1 SRX3931056 | MCF-7 Breast | 201 / 12902 (1.6%) | 6550 / 129020 (5.1%) | −92.1 | −90.2 | 0.31 |
| JUND SRX150408 | HeLa Uterus | 296 / 12902 (2.3%) | 8078 / 129020 (6.3%) | −92.1 | −90.2 | 0.37 |
| Epitope tags SRX5877914 | U2OS Bone | 1728 / 12902 (13.4%) | 26597 / 129020 (20.6%) | −92.0 | −90.1 | 0.65 |
| JUNB SRX8488089 | SUM 229PE Breast | 338 / 12902 (2.6%) | 8716 / 129020 (6.8%) | −91.9 | −90.0 | 0.39 |
| JUND SRX092301 | K-562 Blood | 433 / 12902 (3.4%) | 10120 / 129020 (7.8%) | −91.9 | −90.0 | 0.43 |
| JUN SRX6582172 | Fibroblasts Others | 437 / 12902 (3.4%) | 10180 / 129020 (7.9%) | −91.8 | −89.9 | 0.43 |
| JUNB SRX10119384 | MCF 10A Breast | 208 / 12902 (1.6%) | 6652 / 129020 (5.2%) | −91.7 | −89.8 | 0.31 |
| FOXA1 SRX3931032 | MCF-7 Breast | 198 / 12902 (1.5%) | 6486 / 129020 (5.0%) | −91.7 | −89.8 | 0.31 |
| BMI1 SRX644729 | 293 Kidney | 163 / 12902 (1.3%) | 123 / 129020 (0.1%) | −91.6 | −89.7 | 13.25 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 146 / 12902 (1.1%) | 5580 / 129020 (4.3%) | −91.6 | −89.7 | 0.26 |
| KMT2C SRX1787675 | MCF-7 Breast | 300 / 12902 (2.3%) | 8117 / 129020 (6.3%) | −91.5 | −89.6 | 0.37 |
| STAT3 SRX5323860 | MCF-7 Breast | 422 / 12902 (3.3%) | 9946 / 129020 (7.7%) | −91.5 | −89.6 | 0.42 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1350 / 12902 (10.5%) | 7228 / 129020 (5.6%) | −91.4 | −89.5 | 1.87 |
| NR3C1 SRX2609664 | HASM2 Lung | 464 / 12902 (3.6%) | 10551 / 129020 (8.2%) | −91.4 | −89.5 | 0.44 |
| ESR1 SRX2881001 | MCF-7 Breast | 191 / 12902 (1.5%) | 6358 / 129020 (4.9%) | −91.3 | −89.4 | 0.30 |
| ESR1 SRX176856 | MCF-7 Breast | 120 / 12902 (0.9%) | 5097 / 129020 (4.0%) | −91.3 | −89.4 | 0.24 |
| ESR1 SRX792933 | LY2 Breast | 282 / 12902 (2.2%) | 7828 / 129020 (6.1%) | −91.2 | −89.3 | 0.36 |
| KAT7 DRX234808 | 293 Kidney | 536 / 12902 (4.2%) | 1781 / 129020 (1.4%) | −91.1 | −89.2 | 3.01 |
| FOXA1 SRX6878603 | LNCAP Prostate | 377 / 12902 (2.9%) | 9274 / 129020 (7.2%) | −91.1 | −89.2 | 0.41 |
| ESR1 SRX7624162 | T-47D Breast | 194 / 12902 (1.5%) | 6397 / 129020 (5.0%) | −91.1 | −89.2 | 0.30 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1333 / 12902 (10.3%) | 7109 / 129020 (5.5%) | −91.1 | −89.2 | 1.88 |
| RAD21 SRX2630358 | Liver Liver | 631 / 12902 (4.9%) | 12859 / 129020 (10.0%) | −91.0 | −89.1 | 0.49 |
| JUND SRX150648 | K-562 Blood | 433 / 12902 (3.4%) | 10083 / 129020 (7.8%) | −90.9 | −89.0 | 0.43 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 467 / 12902 (3.6%) | 10570 / 129020 (8.2%) | −90.9 | −89.0 | 0.44 |
| EP300 SRX2194266 | SUM 159PT Breast | 568 / 12902 (4.4%) | 11983 / 129020 (9.3%) | −90.7 | −88.8 | 0.47 |
| ESR1 SRX5534831 | MCF-7 Breast | 272 / 12902 (2.1%) | 7651 / 129020 (5.9%) | −90.7 | −88.8 | 0.36 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 354 / 12902 (2.7%) | 8908 / 129020 (6.9%) | −90.6 | −88.7 | 0.40 |
| SP1 SRX190358 | HCT 116 Digestive tract | 506 / 12902 (3.9%) | 11107 / 129020 (8.6%) | −90.4 | −88.6 | 0.46 |
| Epitope tags SRX20741907 | Hep G2 Liver | 446 / 12902 (3.5%) | 10250 / 129020 (7.9%) | −90.4 | −88.5 | 0.44 |
| ESR1 SRX2513519 | MCF-7 Breast | 190 / 12902 (1.5%) | 6308 / 129020 (4.9%) | −90.4 | −88.5 | 0.30 |
| SREBF2 SRX5359048 | HCC70 Breast | 1177 / 12902 (9.1%) | 5999 / 129020 (4.6%) | −90.0 | −88.2 | 1.96 |
| ARID1A SRX5089382 | MCF-7 Breast | 243 / 12902 (1.9%) | 7170 / 129020 (5.6%) | −90.0 | −88.1 | 0.34 |
| AHR SRX20282969 | MCF-7 Breast | 162 / 12902 (1.3%) | 5810 / 129020 (4.5%) | −89.9 | −88.0 | 0.28 |
| TLE3 SRX4815194 | SUM 149PT Breast | 268 / 12902 (2.1%) | 7561 / 129020 (5.9%) | −89.9 | −88.0 | 0.35 |
| NR3C1 SRX19024870 | MCF-7 Breast | 116 / 12902 (0.9%) | 4968 / 129020 (3.9%) | −89.5 | −87.7 | 0.23 |
| FOXA1 SRX5203294 | MCF-7 Breast | 101 / 12902 (0.8%) | 4684 / 129020 (3.6%) | −89.5 | −87.7 | 0.22 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 136 / 12902 (1.1%) | 5329 / 129020 (4.1%) | −89.3 | −87.4 | 0.26 |
| ESR1 SRX1012631 | MCF-7 Breast | 157 / 12902 (1.2%) | 5702 / 129020 (4.4%) | −89.3 | −87.4 | 0.28 |
| RAD21 SRX2636489 | Liver Liver | 609 / 12902 (4.7%) | 12481 / 129020 (9.7%) | −89.2 | −87.4 | 0.49 |
| EP300 SRX100544 | Hep G2 Liver | 265 / 12902 (2.1%) | 7491 / 129020 (5.8%) | −89.2 | −87.4 | 0.35 |
| FOSL2 SRX10475315 | Hep G2 Liver | 375 / 12902 (2.9%) | 9168 / 129020 (7.1%) | −89.2 | −87.4 | 0.41 |
| FOS SRX3322637 | MCF-7 Breast | 183 / 12902 (1.4%) | 6149 / 129020 (4.8%) | −89.2 | −87.3 | 0.30 |
| Epitope tags SRX20741925 | Hep G2 Liver | 576 / 12902 (4.5%) | 12028 / 129020 (9.3%) | −89.2 | −87.3 | 0.48 |
| SSRP1 SRX3436566 | HT-1080 Bone | 216 / 12902 (1.7%) | 289 / 129020 (0.2%) | −89.1 | −87.2 | 7.47 |
| FOXA1 SRX5323846 | MCF-7 Breast | 132 / 12902 (1.0%) | 5249 / 129020 (4.1%) | −89.1 | −87.2 | 0.25 |
| FOXA1 SRX5203307 | MCF-7 Breast | 105 / 12902 (0.8%) | 4740 / 129020 (3.7%) | −88.9 | −87.0 | 0.22 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 436 / 12902 (3.4%) | 10033 / 129020 (7.8%) | −88.6 | −86.7 | 0.43 |
| MYC SRX150570 | MCF 10A Breast | 231 / 12902 (1.8%) | 6924 / 129020 (5.4%) | −88.6 | −86.7 | 0.33 |
| ZNF219 SRX3230413 | Hep G2 Liver | 575 / 12902 (4.5%) | 11984 / 129020 (9.3%) | −88.4 | −86.6 | 0.48 |
| FOXA1 SRX15431000 | T-47D Breast | 285 / 12902 (2.2%) | 7777 / 129020 (6.0%) | −88.4 | −86.6 | 0.37 |
| HOXC5 SRX2731653 | PC-3 Prostate | 284 / 12902 (2.2%) | 7753 / 129020 (6.0%) | −88.3 | −86.4 | 0.37 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 156 / 12902 (1.2%) | 116 / 129020 (0.1%) | −88.3 | −86.4 | 13.45 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1127 / 12902 (8.7%) | 5688 / 129020 (4.4%) | −88.2 | −86.3 | 1.98 |
| PGR SRX3990996 | T-47D Breast | 344 / 12902 (2.7%) | 8662 / 129020 (6.7%) | −88.1 | −86.2 | 0.40 |
| ESR1 SRX330068 | MCF-7 Breast | 172 / 12902 (1.3%) | 5923 / 129020 (4.6%) | −88.1 | −86.2 | 0.29 |
| ESR1 SRX1012628 | MCF-7 Breast | 184 / 12902 (1.4%) | 6130 / 129020 (4.8%) | −88.1 | −86.2 | 0.30 |
| ESR1 SRX1012630 | MCF-7 Breast | 140 / 12902 (1.1%) | 5361 / 129020 (4.2%) | −88.0 | −86.2 | 0.26 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 935 / 12902 (7.2%) | 4352 / 129020 (3.4%) | −88.0 | −86.2 | 2.15 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 303 / 12902 (2.3%) | 8028 / 129020 (6.2%) | −87.8 | −85.9 | 0.38 |
| BRD4 SRX3031983 | MV-4-11 Blood | 453 / 12902 (3.5%) | 10245 / 129020 (7.9%) | −87.7 | −85.9 | 0.44 |
| ESR1 SRX5323874 | MCF-7 Breast | 210 / 12902 (1.6%) | 6550 / 129020 (5.1%) | −87.7 | −85.8 | 0.32 |
| ESR1 SRX3110723 | MCF-7 Breast | 198 / 12902 (1.5%) | 6351 / 129020 (4.9%) | −87.7 | −85.8 | 0.31 |
| SP1 SRX5457222 | Liver Liver | 575 / 12902 (4.5%) | 11946 / 129020 (9.3%) | −87.7 | −85.8 | 0.48 |
| JUND SRX190357 | SK-N-SH Neural | 433 / 12902 (3.4%) | 9953 / 129020 (7.7%) | −87.7 | −85.8 | 0.44 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 582 / 12902 (4.5%) | 12041 / 129020 (9.3%) | −87.6 | −85.7 | 0.48 |
| ESR1 SRX1012625 | MCF-7 Breast | 192 / 12902 (1.5%) | 6247 / 129020 (4.8%) | −87.6 | −85.7 | 0.31 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 345 / 12902 (2.7%) | 8655 / 129020 (6.7%) | −87.5 | −85.6 | 0.40 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 297 / 12902 (2.3%) | 7925 / 129020 (6.1%) | −87.5 | −85.6 | 0.37 |
| GFP SRX6949256 | HeLa Uterus | 377 / 12902 (2.9%) | 9130 / 129020 (7.1%) | −87.4 | −85.6 | 0.41 |
| TEAD1 SRX2636000 | Hep G2 Liver | 202 / 12902 (1.6%) | 6407 / 129020 (5.0%) | −87.3 | −85.4 | 0.32 |
| TRPS1 SRX3401273 | MCF-7 Breast | 123 / 12902 (1.0%) | 5027 / 129020 (3.9%) | −87.2 | −85.4 | 0.24 |
| 5-mC SRX882968 | LNCAP Prostate | 1906 / 12902 (14.8%) | 11659 / 129020 (9.0%) | −87.2 | −85.4 | 1.63 |
| ESR1 SRX1995229 | MCF-7 Breast | 350 / 12902 (2.7%) | 8717 / 129020 (6.8%) | −87.2 | −85.3 | 0.40 |
| ARID1A SRX5089385 | MCF-7 Breast | 264 / 12902 (2.0%) | 7398 / 129020 (5.7%) | −87.1 | −85.3 | 0.36 |
| CEBPA SRX2630242 | Hep G2 Liver | 173 / 12902 (1.3%) | 5907 / 129020 (4.6%) | −87.1 | −85.2 | 0.29 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 106 / 12902 (0.8%) | 4700 / 129020 (3.6%) | −87.0 | −85.1 | 0.23 |
| DPF2 SRX3927297 | MOLM-13 Blood | 403 / 12902 (3.1%) | 9487 / 129020 (7.4%) | −86.9 | −85.1 | 0.42 |
| CBX3 SRX6712570 | MCF-7 Breast | 282 / 12902 (2.2%) | 7674 / 129020 (5.9%) | −86.9 | −85.0 | 0.37 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 593 / 12902 (4.6%) | 12159 / 129020 (9.4%) | −86.8 | −84.9 | 0.49 |
| VGLL1 SRX18013278 | FULVR Breast | 175 / 12902 (1.4%) | 5932 / 129020 (4.6%) | −86.7 | −84.9 | 0.30 |
| FOXA1 SRX6860635 | T-47D Breast | 272 / 12902 (2.1%) | 7506 / 129020 (5.8%) | −86.6 | −84.8 | 0.36 |
| FOXA1 SRX190181 | A549 Lung | 259 / 12902 (2.0%) | 7299 / 129020 (5.7%) | −86.5 | −84.6 | 0.35 |
| TET2 SRX8617001 | MCF-7 Breast | 239 / 12902 (1.9%) | 6977 / 129020 (5.4%) | −86.5 | −84.6 | 0.34 |
| ESR1 SRX10365534 | MCF-7 Breast | 110 / 12902 (0.9%) | 4764 / 129020 (3.7%) | −86.5 | −84.6 | 0.23 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 938 / 12902 (7.3%) | 16674 / 129020 (12.9%) | −86.4 | −84.6 | 0.56 |
| AR SRX15946405 | MDA-MB-453 Breast | 233 / 12902 (1.8%) | 6880 / 129020 (5.3%) | −86.4 | −84.6 | 0.34 |
| AHR SRX2378695 | MCF-7 Breast | 157 / 12902 (1.2%) | 5600 / 129020 (4.3%) | −86.2 | −84.3 | 0.28 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 122 / 12902 (0.9%) | 4975 / 129020 (3.9%) | −86.1 | −84.3 | 0.25 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1081 / 12902 (8.4%) | 5416 / 129020 (4.2%) | −86.0 | −84.2 | 2.00 |
| AR SRX11149848 | MDA-MB-453 Breast | 234 / 12902 (1.8%) | 6884 / 129020 (5.3%) | −86.0 | −84.1 | 0.34 |
| NR3C1 SRX17639412 | A549 Lung | 389 / 12902 (3.0%) | 9245 / 129020 (7.2%) | −86.0 | −84.1 | 0.42 |
| FOXA2 SRX10475774 | Hep G2 Liver | 161 / 12902 (1.2%) | 5660 / 129020 (4.4%) | −85.8 | −84.0 | 0.28 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 289 / 12902 (2.2%) | 7738 / 129020 (6.0%) | −85.8 | −83.9 | 0.37 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 177 / 12902 (1.4%) | 5928 / 129020 (4.6%) | −85.7 | −83.8 | 0.30 |
| JUN SRX6582163 | BJ-5ta Epidermis | 435 / 12902 (3.4%) | 9899 / 129020 (7.7%) | −85.6 | −83.7 | 0.44 |
| EP300 SRX2194265 | SUM 159PT Breast | 528 / 12902 (4.1%) | 11208 / 129020 (8.7%) | −85.5 | −83.7 | 0.47 |
Showing first 500 of 16798 rows.